Medifast, Inc.
MED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $150,247 | $154,424 | $147,579 | $192,728 |
| - Cash | $99,526 | $101,694 | $91,717 | $90,928 |
| + Debt | $12,261 | $13,068 | $14,610 | $16,125 |
| Enterprise Value | $62,982 | $65,798 | $70,472 | $117,925 |
| Revenue | $89,409 | $105,555 | $115,728 | $119,003 |
| % Growth | -15.3% | -8.8% | -2.8% | – |
| Gross Profit | $62,159 | $76,644 | $84,245 | $88,219 |
| % Margin | 69.5% | 72.6% | 72.8% | 74.1% |
| EBITDA | $795 | $2,979 | $2,018 | $3,894 |
| % Margin | 0.9% | 2.8% | 1.7% | 3.3% |
| Net Income | -$2,261 | $2,480 | -$772 | $801 |
| % Margin | -2.5% | 2.3% | -0.7% | 0.7% |
| EPS Diluted | -0.21 | 0.22 | -0.07 | 0.07 |
| % Growth | -195.5% | 414.3% | -200% | – |
| Operating Cash Flow | $12,113 | -$3,378 | $3,406 | -$4,947 |
| Capital Expenditures | -$1,363 | -$1,378 | -$1,522 | -$2,285 |
| Free Cash Flow | $10,750 | -$4,756 | $1,884 | -$7,232 |